Back to CBIO

GOLDMAN SACHS GROUP INC → CBIO

GOLDMAN SACHS GROUP INC CBIO Position History

Crescent Biopharma, Inc. • Healthcare

Quarters held
1
Latest value
$3.3M
Q3 2026
Peak value
$3.3M
First seen
Q3 2026

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$3.3M227.3K——

Other funds holding CBIO

Other GOLDMAN SACHS GROUP INC positions

NVDA

NVIDIA CORPORATION

$37B
AAPL

APPLE INC

$31.7B
NVDA

NVIDIA CORPORATION

$31.3B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.3B
AAPL

APPLE INC

$26.9B
NVDA

NVIDIA CORPORATION

$26.5B